Company: LENZ
Filing Date: 2025-04-28
Form Type: DEFA14A
Source: 0001193125-25-100656
Chunk: 1

Company: LENZ Therapeutics, Inc.
Filing Date: 2025-04-28
Form: DEFA14A
Chunk 1
---
 participate atwww.proxydocs.com/LENZFor a convenient way to view proxy materials, VOTE, and obtaindirections to attend the meeting go to www.proxydocs.com/LENZTo vote your proxy while visiting this site, you will need the 12 digitcontrol number in the box below.This communication presents only an overview of the more complete proxy materials that areavailable to you on the Internet. This is not a ballot. You cannot use this notice to vote yourshares. We encourage you to access and review all of the important information contained inthe proxy materials before voting.Under United States Securities and Exchange Commission rules, proxy materials do not haveto be delivered in paper. Proxy materials can be distributed by making them available on theinternet.If you want to receive a paper or e-mailcopy of the proxy material, you must request one.There is no charge to you for requesting a copy. In order to receive a paper package in timefor this year’s meeting, you must make this request on or before June 2, 2025.styleINAP.O. BOX 8016, CARY, NC 27512-9903SEE REVERSE FOR FULL AGENDAPROPOSAL1. To elect two Class III directors to hold office until our 2027 annual meeting of stockholders and two Class I directors to hold office until our 2028annual meeting of stockholders, each until their respective successors are elected and qualified.Class III:1.01 Kimberlee C. Drapkin1.02 Zach ScheinerClass I:1.03 Frederic Guerard1.04 James McCollum2. To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31,2025.FOR EACH OF THE NOMINEES LISTED IN PROPOSAL 1 AND FOR PROPOSAL 2LENZ Therapeutics, Inc. Annual Meeting of Stockholders

PROPOSAL1. To elect two Class III directors to hold office until our 2027 annual meeting of stockholders and two Class I directors to hold office until our 2028annual meeting of stockholders, each until their respective successors are elected and qualified.Class III:1.01 Kimberlee C. Drapkin1.02 Zach ScheinerClass I:1.03 Frederic Guerard1.04 James McCollum2. To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31,2025